The Food and Drug Administration has approved Opdivo before and after surgery for some with non-small cell lung cancer.

The antibody-drug conjugate will be reviewed for the potential treatment of previously treated, unresectable or metastatic ...

Researchers are advising against the interruption of treatment with Gleevec among patients with advanced gastrointestinal ...

After recently losing my aunt, I realized that cancer has given me a new perspective on life, which reminds me that every day ...

Among patients with HR+/HER2+ breast cancer, Herceptin and Perjeta plus endocrine therapy proved to be beneficial without ...

Patients with soft tissue sarcomas showed improved functional results, quality of life and fewer side effects when treated ...

An expert explains study findings that associate a longer time until postsurgical melanoma recurrence with improved ...

For patients with prostate cancer, theranostics may be another available treatment path to take, especially for those who ...

Throughout September, the FDA approved drugs for the treatment of diseases including lung cancer, multiple myeloma, thyroid ...

Keytruda continued to improve survival versus Yervoy in unresectable stage 3 or 4 melanoma in long-term follow-up data.

Fotivda monotherapy may show better outcomes in second-line therapy than the combination of Opdivo and Fotivda in metastatic ...

As a breast cancer survivor, I’ve learned to navigate the annual sea of pink, but I don’t like it. October has become well ...